4PXM | The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with Estradiol and a glucocorticoid receptor-interacting protein 1 NR box II peptide | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Fanning, S.W., Panchamukhi, S., Greene, G.L. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 | ||||||||||||
ligand | EST | enzyme |
| ||||||||||||
Primary reference | Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation., Fanning SW, Mayne CG, Dharmarajan V, Carlson KE, Martin TA, Novick SJ, Toy W, Green B, Panchamukhi S, Katzenellenbogen BS, Tajkhorshid E, Griffin PR, Shen Y, Chandarlapaty S, Katzenellenbogen JA, Greene GL, Elife. 2016 Feb 2;5. pii: e12792. doi: 10.7554/eLife.12792. PMID:26836308 |
Data retrieval |
View 4PXM in 3D |
Visual 3D analysis of 4PXM |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4PXM |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |